Want to see IN:LASA full AI Analyst Report?
Lasa Supergenerics Ltd. (LASA) Ratios
Lasa Supergenerics Ltd. Ratios
IN:LASA's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:LASA's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.62 | 1.90 | 0.78 | 0.92 | 1.48 |
| Quick Ratio | 0.51 | 0.47 | 0.39 | 0.59 | 1.22 |
| Cash Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.25 |
| Solvency Ratio | -1.66 | -0.14 | -0.20 | -0.55 | 0.18 |
| Operating Cash Flow Ratio | -0.48 | -0.16 | 0.04 | -0.40 | 0.21 |
| Short-Term Operating Cash Flow Coverage | -0.83 | -1.33 | 0.10 | -0.79 | 0.46 |
| Net Current Asset Value | $ -65.07M | $ 146.95M | $ -163.03M | $ -63.49M | $ 150.12M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.02 | 0.15 | 0.13 | 0.10 |
| Debt-to-Equity Ratio | 0.20 | 0.03 | 0.23 | 0.18 | 0.13 |
| Debt-to-Capital Ratio | 0.16 | 0.02 | 0.19 | 0.16 | 0.11 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.34 | 1.21 | 1.56 | 1.39 | 1.32 |
| Debt Service Coverage Ratio | -2.73 | 0.05 | -0.38 | -0.81 | 0.46 |
| Interest Coverage Ratio | -34.66 | -2.24 | -4.27 | -4.35 | 57.69 |
| Debt to Market Cap | 0.34 | 0.02 | 0.19 | 0.23 | 0.10 |
| Interest Debt Per Share | 2.02 | 0.96 | 4.80 | 5.18 | 4.02 |
| Net Debt to EBITDA | -0.34 | -0.42 | -3.32 | -0.85 | 1.08 |
| Profitability Margins | |||||
| Gross Profit Margin | -27.41% | 25.46% | 27.50% | -8.63% | 31.20% |
| EBIT Margin | -136.12% | -11.72% | -16.43% | -29.41% | -4.46% |
| EBITDA Margin | -112.19% | -3.08% | -6.20% | -19.05% | 6.13% |
| Operating Profit Margin | -53.24% | -4.24% | -8.08% | -13.97% | 1.70% |
| Pretax Profit Margin | -137.66% | -13.61% | -18.32% | -32.62% | -4.48% |
| Net Profit Margin | -135.60% | -10.36% | -20.83% | -29.81% | -3.89% |
| Continuous Operations Profit Margin | -135.60% | -10.36% | -20.83% | -29.81% | -3.89% |
| Net Income Per EBT | 98.50% | 76.14% | 113.70% | 91.38% | 86.84% |
| EBT Per EBIT | 258.58% | 321.24% | 226.68% | 233.53% | -264.05% |
| Return on Assets (ROA) | -51.21% | -14.53% | -14.40% | -23.57% | -2.55% |
| Return on Equity (ROE) | -68.70% | -17.63% | -22.48% | -32.65% | -3.38% |
| Return on Capital Employed (ROCE) | -26.88% | -7.15% | -8.27% | -14.94% | 1.41% |
| Return on Invested Capital (ROIC) | -22.14% | -5.31% | -6.80% | -11.57% | 1.09% |
| Return on Tangible Assets | -68.32% | -18.08% | -17.39% | -29.03% | -2.77% |
| Earnings Yield | -119.93% | -16.32% | -18.79% | -41.56% | -2.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 275.67 | 92.40 | 28.69 | 1891.50 | 7.37 |
| Payables Turnover | 15.09 | 10.39 | 5.35 | 14.93 | 10.01 |
| Inventory Turnover | 17.64 | 4.33 | 3.95 | 10.12 | 8.21 |
| Fixed Asset Turnover | 0.66 | 2.95 | 1.21 | 1.40 | 1.10 |
| Asset Turnover | 0.38 | 1.40 | 0.69 | 0.79 | 0.66 |
| Working Capital Turnover Ratio | 5.57 | 65.07 | -14.40 | 14.36 | 6.05 |
| Cash Conversion Cycle | -2.18 | 53.03 | 36.94 | 11.80 | 57.54 |
| Days of Sales Outstanding | 1.32 | 3.95 | 12.72 | 0.19 | 49.53 |
| Days of Inventory Outstanding | 20.69 | 84.20 | 92.41 | 36.05 | 44.48 |
| Days of Payables Outstanding | 24.19 | 35.12 | 68.20 | 24.45 | 36.47 |
| Operating Cycle | 22.02 | 88.15 | 105.13 | 36.25 | 94.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.61 | -0.56 | 0.43 | -3.45 | 1.83 |
| Free Cash Flow Per Share | 0.00 | -0.56 | 0.43 | -3.45 | 1.83 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | 0.00 | -13.81 | 0.88 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | 0.99 |
| Operating Cash Flow Coverage Ratio | -0.83 | -1.33 | 0.10 | -0.79 | 0.46 |
| Operating Cash Flow to Sales Ratio | -0.32 | -0.02 | 0.02 | -0.13 | 0.07 |
| Free Cash Flow Yield | 0.00% | -3.12% | 1.85% | -18.62% | 4.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.83 | -6.13 | -5.32 | -2.41 | -39.43 |
| Price-to-Sales (P/S) Ratio | 1.13 | 0.63 | 1.11 | 0.72 | 1.53 |
| Price-to-Book (P/B) Ratio | 0.57 | 1.08 | 1.20 | 0.79 | 1.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -32.03 | 54.08 | -5.37 | 22.82 |
| Price-to-Operating Cash Flow Ratio | -3.52 | -32.03 | 54.08 | -5.37 | 22.82 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.19 | 0.12 | -0.00 | 0.33 |
| Enterprise Value Multiple | -1.34 | -21.02 | -21.21 | -4.61 | 26.07 |
| Enterprise Value | 378.85M | 922.97M | 1.37B | 1.14B | 2.19B |
| EV to EBITDA | -1.34 | -21.02 | -21.21 | -4.61 | 26.07 |
| EV to Sales | 1.51 | 0.65 | 1.31 | 0.88 | 1.60 |
| EV to Free Cash Flow | 0.00 | -32.69 | 64.12 | -6.58 | 23.81 |
| EV to Operating Cash Flow | -4.70 | -32.69 | 64.12 | -6.58 | 23.81 |
| Tangible Book Value Per Share | 6.57 | 10.55 | 14.13 | 17.46 | 28.06 |
| Shareholders’ Equity Per Share | 9.90 | 16.73 | 19.31 | 23.61 | 31.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | 0.24 | -0.14 | 0.09 | 0.13 |
| Revenue Per Share | 5.01 | 28.48 | 20.84 | 25.86 | 27.26 |
| Net Income Per Share | -6.80 | -2.95 | -4.34 | -7.71 | -1.06 |
| Tax Burden | 0.99 | 0.76 | 1.14 | 0.91 | 0.87 |
| Interest Burden | 1.01 | 1.16 | 1.12 | 1.11 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.26 | 0.04 | 0.03 | 0.03 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.24 | 0.15 | -0.10 | 0.77 | 5.58 |
Currency in INR